Marriage Counselors in Johnston, IA Accepting Medicare

4 Marriage Counselors found. Showing 1 - 4

David Kaptain Marriage & Family Therapist Medicare: Medicare Enrolled Practice Location: 5415 Nw 88th St, Ste 100, Johnston, IA 50131 Phone: 515-727-1338

Gloria Scholl, MA, Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 5920 Century Way E, Johnston, IA 50131 Phone: 515-669-8038

Taylor Mae Zaun, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 5415 Nw 88th St Ste 100, Johnston, IA 50131 Phone: 515-727-1338

Tabitha June Norgaard Nicolaysen, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 5415 Nw 88th St, Suite 100, Johnston, IA 50131 Phone: 515-727-1338

News Archive

MIT MEMS device provides precise way to physically arrange cells

Now MIT researchers led by Sangeeta Bhatia, associate professor of electrical engineering and computer science at the Harvard-MIT Division of Health Sciences and Technology (HST) and Brigham and Women's Hospital, have solved the problem with a novel device.

Children's deaths from choking on small objects drop by 75% in US

Children's deaths from choking on small objects dropped by 75 percent from 1968 to 2017, according to a report published in JAMA. Various choking hazard regulations enacted during the past 50 years may have played a role in the large decline in choking deaths, although the study design cannot establish a direct causal link. However, despite warning label legislation and other regulations, 184 children in the U.S. died from choking in 2017.

Gene therapy for common forms of congenital blindness shows promise to improve vision

A new gene therapy for one of the most common forms of congenital blindness was safe and improved patients' vision, according to initial data from a clinical trial led by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania.

ARIAD Pharmaceuticals' investigational pan-BCR-ABL inhibitor receives FDA and EMA orphan drug designation

ARIAD Pharmaceuticals, Inc. today announced that its investigational pan-BCR-ABL inhibitor, AP24534, has been granted orphan drug designation by both the U. S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). In the U.S., the orphan designation of AP24534 is for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and in the E.U., its orphan designation is for CML and acute lymphoblastic leukemia.

Read more Medical News

› Verified 7 days ago